Featured Research

from universities, journals, and other organizations

For CABG, use of artery from arm does not appear to be superior to vein grafts from the leg

Date:
January 11, 2011
Source:
JAMA and Archives Journals
Summary:
Use of a radial artery (located within the forearm, wrist and hand) graft compared with a saphenous vein (from the leg) graft for coronary artery bypass grafting did not result in improved angiographic patency (the graft being open, unobstructed) one year after the procedure, according to a new study.

Use of a radial artery (located within the forearm, wrist and hand) graft compared with a saphenous vein (from the leg) graft for coronary artery bypass grafting did not result in improved angiographic patency (the graft being open, unobstructed) one year after the procedure, according to a new study.

Coronary artery bypass grafting (CABG) is one of the most common operations performed, with a database indicating that in the United States, 163,048 patients had CABG surgery in 2008. The success of CABG depends on the long-term patency of the arterial and venous grafts. Arterial grafts are thought to be better conduits than saphenous vein grafts for CABG based on experience with using the left internal mammary (breast) artery to bypass the left anterior descending coronary artery, according to background information in the article. The efficacy of the radial artery graft, which is easier to harvest than other arteries, is less clear. A database shows that more than 10,000 patients in the United States received radial artery grafts in 2008, suggesting that about 6 percent of patients undergoing CABG have radial artery grafts.

Steven Goldman, M.D., of the Southern Arizona VA Health Care System and the University of Arizona Sarver Heart Center, Tucson, and colleagues compared 1-year angiographic patency of radial artery grafts vs. saphenous vein grafts in 757 participants (99 percent men) undergoing elective first-time CABG. The randomized controlled trial was conducted from February 2003 to February 2009 at 11 Veterans Affairs medical centers. The left internal mammary artery was used to preferentially graft the left anterior descending coronary artery whenever possible; the best remaining recipient vessel was randomized to radial artery vs. saphenous vein graft. The primary outcome measured was angiographic graft patency at 1 year after CABG. Secondary outcomes included angiographic graft patency at 1 week after CABG, heart attack, stroke, repeat revascularization and death.

The analysis included 733 patients (366 in the radial artery group, 367 in the saphenous vein group). The researchers found that there was no significant difference in 1-year graft patency between radial artery (238/266; 89 percent) and saphenous vein grafts (239/269; 89 percent). Also, there was no significant difference in 1-week patency between patients who received radial artery grafts (285/288; 99 percent) vs. saphenous vein grafts (260/267; 97 percent), or in the other secondary outcomes. There was no difference in the number and types of adverse events, including serious adverse events.

"Although most clinicians assume that compared with vein grafts, arterial grafts have an improved patency rate, there are little multi-institutional prospective data on radial artery graft vs. saphenous vein graft patency," the authors write.

Because the important question is long-term patency, the researchers note that there will be a 5-year angiographic follow-up of these patients to define chronic graft patency in this population.


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. Goldman, G. K. Sethi, W. Holman, H. Thai, E. McFalls, H. B. Ward, R. F. Kelly, B. Rhenman, G. H. Tobler, F. G. Bakaeen, J. Huh, E. Soltero, M. Moursi, M. Haime, M. Crittenden, V. Kasirajan, M. Ratliff, S. Pett, A. Irimpen, W. Gunnar, D. Thomas, S. Fremes, T. Moritz, D. Reda, L. Harrison, T. H. Wagner, Y. Wang, L. Planting, M. Miller, Y. Rodriguez, E. Juneman, D. Morrison, M. K. Pierce, S. Kreamer, M.-C. Shih, K. Lee. Radial Artery Grafts vs Saphenous Vein Grafts in Coronary Artery Bypass Surgery: A Randomized Trial. JAMA: The Journal of the American Medical Association, 2011; 305 (2): 167 DOI: 10.1001/jama.2010.1976

Cite This Page:

JAMA and Archives Journals. "For CABG, use of artery from arm does not appear to be superior to vein grafts from the leg." ScienceDaily. ScienceDaily, 11 January 2011. <www.sciencedaily.com/releases/2011/01/110111165011.htm>.
JAMA and Archives Journals. (2011, January 11). For CABG, use of artery from arm does not appear to be superior to vein grafts from the leg. ScienceDaily. Retrieved September 30, 2014 from www.sciencedaily.com/releases/2011/01/110111165011.htm
JAMA and Archives Journals. "For CABG, use of artery from arm does not appear to be superior to vein grafts from the leg." ScienceDaily. www.sciencedaily.com/releases/2011/01/110111165011.htm (accessed September 30, 2014).

Share This



More Health & Medicine News

Tuesday, September 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins